Meet the Nominees for the Americans for Safe Access 2026 Awards

Court to Hear Key Case on Psilocybin Services Accessibility in Oregon

Update A Historic Case for Psilocybin Access An important legal battle is set to unfold that could reshape access to psilocybin services in Oregon. On November 16, 2026, the U.S. District Court in Eugene will hear the case of Cusker et al. v. Oregon Health Authority (OHA), a critical moment for ensuring that individuals who are homebound, disabled, or terminally ill can obtain psilocybin-assisted therapy. In a world where mental health concerns are increasingly at the forefront, the implications of this case could be monumental. The Plaintiffs' Stand The lawsuit was filed by licensed psilocybin facilitators Jay Cusker, LMFT, Alison Grayson, and Kathryn Kloos, ND, along with Dr. Yolanda Suarez, DO, a physician familiar with end-of-life care. Their argument rests on the premise that OHA's current regulations, which limit psilocybin consumption to licensed service centers, violate the Americans with Disabilities Act (ADA). Given the evidence that psilocybin can alleviate anxiety and depression for terminal patients, it raises the poignant question: why deny access to those who need it most? The Importance of Reasonable Accommodation Each plaintiff brings a personal story to the court. They recount the heart-wrenching experiences of patients who have passed away without receiving the psilocybin-assisted therapy that could have eased their existential distress. The OHA’s steadfast position has been that there is "no legal pathway" for psilocybin consumption outside licensed centers. However, the plaintiffs are challenging this, asserting that the ADA provides that necessary pathway for accommodations. A Broader Dialogue on Psilocybin and Health Care This case isn’t just about legal compliance; it's fundamentally about human rights and the right to access care. Psilocybin-assisted therapy has shown promise in various therapeutic settings, particularly in hospice care. The tension surrounding the regulatory framework suggests deeper cultural and ethical considerations about mental health therapies. A victory for the plaintiffs could set a precedent, advocating for broader access to not just psilocybin, but to alternative healing modalities in general. Getting Involved: Community Support This upcoming oral argument is open to the public, and community attendance is highly encouraged. If you are in Eugene on that day, your presence could resonate as a testament to collective advocacy for mental health and the rights of people with disabilities. The importance of community involvement cannot be understated when facing such vital issues. As we approach this critical point in the ongoing debate over psilocybin services, the eyes of advocates, healthcare professionals, and those affected by terminal illnesses will be watching closely. Together, we can continue to push for accessibility and inclusivity in mental health care.